A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer-Reference-Cited by-同舟云学术

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer

Published:2004-03 Issue:3 Volume:15 Page:433-439
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Cresta S.,Grasselli G.,Mansutti M.,Martoni A.,Lelli G.,Capri G.,Buzzi F.,Robustelli Della Cuna G.,Jirillo A.,Terzoli E.,Frevola L.,Tarenzi E.,Sguotti C.,Azli N.,Murawsky M.,Gianni L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/3/433/558796/mdh107.pdf

Reference31 articles.

1. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer;Henderson;J Clin Oncol,1989

2. A multicentre phase II study of the efficacy and safety of docetaxel as first line treatment of advanced breast cancer: report of the EORTC;Fumoleau;Ann Oncol,1996

3. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer;Chan;J Clin Oncol,1999

4. Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer;Ravdin;J Clin Oncol,1995

5. Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer;Misset;Ann Oncol,1999

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma;The Oncologist;2024-09-03

2. Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-23

3. Nanoparticle Albumin-Bound-Paclitaxel Instead of Standard Paclitaxel in Adjuvant Chemotherapy Regimen for Breast Cancer Under COVID-19 Pandemic—A Single Center Feasibility Study in China;Science of Advanced Materials;2022-02-01

4. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice;Critical Reviews in Oncology/Hematology;2020-09

5. Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer;Bladder Cancer;2018